As of April 2024 ACADIA Pharmaceuticals has a market cap of $2.75 Billion. This makes ACADIA Pharmaceuticals the world's 3595th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.75 B | -46.44% |
2023 | $5.14 B | 99.4% |
2022 | $2.57 B | -31.29% |
2021 | $3.75 B | -55.85% |
2020 | $8.49 B | 27.94% |
2019 | $6.64 B | 185.57% |
2018 | $2.32 B | -37.8% |
2017 | $3.73 B | 7.07% |
2016 | $3.49 B | -3.89% |
2015 | $3.63 B | 14.41% |
2014 | $3.17 B | 39.53% |
2013 | $2.27 B | 567.63% |
2012 | $0.34 B | 497.99% |
2011 | $57.02 M | 20.76% |
2010 | $47.22 M | -6.68% |
2009 | $50.59 M | 51.22% |
2008 | $33.46 M | -91.84% |
2007 | $0.40 B | 55.78% |
2006 | $0.26 B | 58.61% |
2005 | $0.16 B | 45.49% |
2004 | $0.11 B |
On Apr 26th, 2024 the market cap of ACADIA Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $352.16 B | 12,690.47% | ๐บ๐ธ USA |
Pfizer PFE | $143.82 B | 5,123.78% | ๐บ๐ธ USA |
Eli Lilly LLY | $697.39 B | 25,229.11% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $90.90 B | 3,201.45% | ๐บ๐ธ USA |
Vanda Pharmaceuticals VNDA | $0.26 B | -90.35% | ๐บ๐ธ USA |
Adamas Pharmaceuticals
ADMS | $0.37 B | -86.33% | ๐บ๐ธ USA |